These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4168588)

  • 21. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of the tolbutamide effect by dicoumarol.
    Kristensen M; Hansen JM
    Diabetes; 1967 Apr; 16(4):211-4. PubMed ID: 4164590
    [No Abstract]   [Full Text] [Related]  

  • 23. Efect of "Dicumarol" (bishydroxycoumarin) on insulin secretion in vitro.
    Günther MA; López-Quijada C; Candela JL
    Life Sci; 1966 Jun; 5(12):1091-5. PubMed ID: 4164320
    [No Abstract]   [Full Text] [Related]  

  • 24. The efficacy of oral tolbutamide in chronic alcoholics.
    Horowitz SH; Johnson BF
    Am J Med Sci; 1972 Nov; 264(5):395-400. PubMed ID: 4650130
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug induced changes of the blood glucose lowering effect of oral hypoglycemic agents].
    Christensen LK; Kristensen M
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():116-36. PubMed ID: 4190079
    [No Abstract]   [Full Text] [Related]  

  • 26. IMPLICATIONS ON ENZYME INDUCTION FOR DRUG THERAPY.
    BURNS JJ
    Am J Med; 1964 Sep; 37():327-31. PubMed ID: 14218162
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetics of tolbutamide metabolism in humans.
    Scott J; Poffenbarger PL
    Diabetes; 1979 Jan; 28(1):41-51. PubMed ID: 569611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for an antithrombotic effect of Dicumarol.
    DEYKIN D; WESSLER S; REIMER SM
    Am J Physiol; 1960 Dec; 199():1161-4. PubMed ID: 13722414
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of bishydroxycoumarin activity by phenobarbital.
    Corn M; Rockett JF
    Med Ann Dist Columbia; 1965 Dec; 34(12):578-9 passim. PubMed ID: 4158838
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased clearance of tolbutamide from the blood of asthmatic patients.
    Sotaniemi E; Arvela P; Huhti E
    Ann Allergy; 1971 Mar; 29(3):139-41. PubMed ID: 5155517
    [No Abstract]   [Full Text] [Related]  

  • 31. [Binding of tolbutamide by cholestyramine in vitro and in vivo].
    Rosenstiel K; Dördelmann E; Berthold K; Bock KD
    Verh Dtsch Ges Inn Med; 1973; 79():1223-5. PubMed ID: 4790142
    [No Abstract]   [Full Text] [Related]  

  • 32. The metabolism of (ureyl-14C)tolbutamide in vitro and in vivo in man.
    Darby FJ; Grundy RK
    Life Sci; 1973 Jul; 13(2):97-105. PubMed ID: 4356419
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-inflammatory evaluation of cryogenine.
    Kaplan HR; Wolke RE; Malone MH
    J Pharm Sci; 1967 Nov; 56(11):1385-92. PubMed ID: 6060584
    [No Abstract]   [Full Text] [Related]  

  • 34. Anticoagulants and cerebral hemodynamics. Action of bishydroxycoumarin.
    KEMPINSKY WH; BONIFACE WR; KEATING JB; WEINSTEN W
    Arch Neurol; 1961 Sep; 5():275-8. PubMed ID: 13752446
    [No Abstract]   [Full Text] [Related]  

  • 35. Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.
    Wing LM; Miners JO
    Br J Clin Pharmacol; 1985 Nov; 20(5):482-5. PubMed ID: 3878154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flaps and flap necrosis. Improving the circulation in skin flaps with Complamin and with Dicoumarol: animal experiments.
    Körlof B; Ugland O
    Acta Chir Scand; 1966 May; 131(5):408-12. PubMed ID: 4164331
    [No Abstract]   [Full Text] [Related]  

  • 37. The anticoagulant response to bishydroxycoumarin. II. The effect of D-thyroxine, clofibrate, and norethandrolone.
    Schrogie JJ; Solomon HM
    Clin Pharmacol Ther; 1967; 8(1):70-7. PubMed ID: 4163172
    [No Abstract]   [Full Text] [Related]  

  • 38. Failure of induction of liver microsomal enzymes by tolbutamide in maturity-onset diabetics.
    Redman DR; Prescott LF
    Diabetes; 1973 Mar; 22(3):210-1. PubMed ID: 4689295
    [No Abstract]   [Full Text] [Related]  

  • 39. Sulfamethizole-induced inhibition of diphenlhydantoin, tolbutamide, and warfarin metabolism.
    Lumholtz B; Siersbaek-Nielsen K; Skovsted L; Kampmann J; Hansen JM
    Clin Pharmacol Ther; 1975 Jun; 17(6):731-4. PubMed ID: 1139863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anticoagulant response to bishydroxycoumarin. I. The role of individual variation.
    Solomon HM; Schrogie JJ
    Clin Pharmacol Ther; 1967; 8(1):65-9. PubMed ID: 4163171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.